RECRUITING

LCI-PED-NOS-EXER-001: Exercise in Pediatric Oncology Patients

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to see if there are physical and emotional benefits to participating in a structured exercise regimen for those who are ages 2-25, are newly diagnosed with a blood or solid tumor cancer, and are currently undergoing or will begin cancer treatment.

Official Title

LCI-PED-NOS-EXER-001: Just Move. A Randomized Controlled Trial Investigating Exercise in Pediatric Oncology Patients

Quick Facts

Study Start:2024-03-11
Study Completion:2025-10-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05058508

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:2 Years to 25 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD, ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Ages 2-25 at time of consent
  2. 2. Subject has newly diagnosed cancer per Investigator, and is planning to undergo chemotherapy for treatment of malignancy
  3. 3. Ability of subject (and/or parent/guardian) to read and understand the English or Spanish language
  4. 4. Subject is anticipated to receive at least 3 months of chemotherapy or other cancer treatment.
  5. 5. As determined and documented by the enrolling investigator, ability of the subject to understand and comply with study procedures for the entire length of the study
  1. 1. Known cardiac dysfunction that, in the opinion of the investigator, would be unsafe for the child to participate in the exercise program
  2. 2. Recent (within 4 weeks of enrollment) or planned surgery that will result in prolonged limited mobility not amendable to exercise modifications per investigator discretion
  3. 3. Primary CNS Tumor
  4. 4. Osteosarcoma

Contacts and Locations

Study Contact

Alicia Patrick
CONTACT
980-292-1746
Alicia.Patrick@atriumhealth.org

Principal Investigator

Jennifer Pope, MD
PRINCIPAL_INVESTIGATOR
Wake Forest University Health Sciences

Study Locations (Sites)

Levine Children's Hospital
Charlotte, North Carolina, 28203
United States

Collaborators and Investigators

Sponsor: Wake Forest University Health Sciences

  • Jennifer Pope, MD, PRINCIPAL_INVESTIGATOR, Wake Forest University Health Sciences

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-03-11
Study Completion Date2025-10-01

Study Record Updates

Study Start Date2024-03-11
Study Completion Date2025-10-01

Terms related to this study

Keywords Provided by Researchers

  • Exercise
  • Pediatric Oncology

Additional Relevant MeSH Terms

  • Pediatric Cancer